Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, November 19, 2007 ) New York, NY,--The ISE-CCM Nanotechnology Index (ISE: TNY) is down -5.78% year to date, versus 9.21% for the S&P 500, 12.16% for the DJIA, and 16.72% for the Nasdaq.TNY was co-developed by Cronus Capital Markets and the International Securities Exchange (ISE) in New York. TNY comprises 17 of the leading Nanotechnology companies such as; Cabot Corp. (NYSE: CBT), Headwaters Inc. (NYSE: HW), Symyx Technologies Inc. (NASDAQ: SMMX), and FEI COMPANY (NASDAQ: FEIC). TNY is currently trading options in the ISE.Cronus Capital Markets CEO Michael Soni remarked that “monthly index reports are an important feature of CCM’s Index Support Program, especially for an index like TNY which covers an important aspect of the capital markets and receives significant investor interest.” CCM Index Reports, available at no cost to investors and the media, include index descriptions, objectives, volatility analysis, performance returns, product specifications, component breakdowns and component profiles with news links. The TNY report is available on www.iseoptions.com Cronus Capital Markets® (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. Our equity indexes receive international attention and represent important new benchmarks of growth.
Dianne Rudderham
rudderham@cronuscapitalmarkets.com
Source: EmailWire.com
|
|
|
|